Literature DB >> 4572536

[Longtime study on the effects of L-dopa therapy in parkinsonism].

P A Fischer, E Schneider, P Jacobi, H Maxion.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4572536

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  6 in total

1.  [Sleep in patients with Parkinson's disease and its influence by L-DOPA (author's transl)].

Authors:  E Schneider; H Maxion; B Ziegler; P Jacobi
Journal:  J Neurol       Date:  1974-06-27       Impact factor: 4.849

2.  [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Authors:  W Gehlen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974-04-09

3.  [General intelligence of patients with parkinsonism during L-dopa medication (author's transl)].

Authors:  P Jacobi; P A Fischer; E Schneider
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974

4.  [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].

Authors:  E Schneider; P A Fischer; P Jacobi; H Maxion
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1973-03-19

5.  The course of brain atrophy in Parkinson's disease.

Authors:  E Schneider; H Becker; P A Fischer; H Grau; P Jacobi; R Brinkmann
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979-07-04

6.  Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued.

Authors:  H Przuntek; D Welzel; E Blümner; W Danielczyk; H Letzel; H J Kaiser; P H Kraus; P Riederer; D Schwarzmann; H Wolf
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.